Circulating Natural Killer T Cells in Patients with Asthma

References

• Robinson D S, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley A M, Corrigan C, Durham S R, Kay A B. Predominant TH2‐like bronchoalveolar T‐lymphocyte population in atopic asthma. N Engl J Med 1992; 326(5)298–304
   PubMed Web of Science ®Google Scholar
• Barnes P J. Th2 cytokines and asthma: an introduction. Respir Res 2001; 2(2)64–65
   PubMed Web of Science ®Google Scholar
• Maziak W. The Th1‐Th2 paradigm and asthma: how far should we go?. J Asthma 2003; 40(2)201–205
   PubMed Web of Science ®Google Scholar
• Menzies‐Gow A, Robinson D S. Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic targets. J Asthma 2001; 38(8)605–613
   PubMed Web of Science ®Google Scholar
• Tournoy K G, Kips J C, Pauwels R A. Is Th1 the solution for Th2 in asthma?. Clin Exp Allergy 2002; 32(1)17–29
   PubMedGoogle Scholar
• Bendelac A, Rivera M N, Park S H, Roark J H. Mouse CD1‐specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997; 535–562
   PubMedGoogle Scholar
• Kim C H, Butcher E C, Johnston B. Distinct subsets of human Vα24‐invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 2002; 23(11)516–519
   PubMedGoogle Scholar
• Lantz O, Bendelac A. An invariant T cell receptor α chain is used by a unique subset of major histocompatibility complex class I‐specific CD4+ and CD4−8−T cells in mice and humans. J Exp Med 1994; 180(3)1097–1106
   PubMed Web of Science ®Google Scholar
• Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2(8)557–568
   PubMed Web of Science ®Google Scholar
• Godfrey D I, Hammond K J, Poulton L D, Smyth M J, Baxter A G. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21(11)573–583
   PubMedGoogle Scholar
• Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d‐restricted and TCR‐mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278(5343)1626–1629
   PubMed Web of Science ®Google Scholar
• Spada F M, Koezuka Y, Porcelli S A. CD1d‐restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998; 188(8)1529–1534
   PubMed Web of Science ®Google Scholar
• Couedel C, Peyrat M A, Brossay L, Koezuka Y, Porcelli S A, Davodeau F, Bonneville M. Diverse CD1d‐restricted reactivity patterns of human T cells bearing “invariant” AV24BV11 TCR. Eur J Immunol 1998; 28(12)4391–4397
   PubMedGoogle Scholar
• Cui J, Watanabe N, Kawano T, Yamashita M, Kamata T, Shimizu C, Kimura M, Shimizu E, Koike J, Koseki H, Tanaka Y, Taniguchi M, Nakayama T‐I. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand‐activated Vα14 natural killer T cells. J Exp Med 1999; 190(6)783–792
   PubMedGoogle Scholar
• Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby M J, DeKruyff R H, Umetsu D T. Essential role of NKT cells producing IL‐4 and IL‐13 in the development of allergen‐induced airway hyperreactivity. Nat Med 2003; 9(5)582–588
   PubMedGoogle Scholar
• Lisbonne M, Diem S, de Castro K A, Lefort J, Araujo L M, Hachem P, Fourneau J M, Sidobre S, Kronenberg M, Taniguchi M, Van E P, Dy M, Askenase P, Russo M, Vargaftig B B, Herbelin A, Leite‐de‐Moraes M C. Cutting edge: invariant Vα14 NKT cells are required for allergen‐induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003; 171(4)1637–1641
   PubMedGoogle Scholar
• Global Strategy for Asthma Management and Prevention, NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung, and Blood Institute, Publication No. 02‐3659, Bethesda, MD 2002
   Google Scholar
• Oishi Y, Sakamoto A, Kurasawa K, Nakajima H, Nakao A, Nakagawa N, Tanabe E, Saito Y, Iwamoto I. CD4−CD8−T cells bearing invariant Vα24JαQ TCR α‐chain are decreased in patients with atopic diseases. Clin Exp Immunol 2000; 119(3)404–411
   PubMedGoogle Scholar
• Takahashi T, Nakamura K, Chiba S, Kanda Y, Tamaki K, Hirai H. Vα24+ natural killer T cells are markedly decreased in atopic dermatitis patients. Hum Immunol, 64(6)586–592
   PubMedGoogle Scholar
• Lee P T, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 2002; 195(5)637–641
   PubMedGoogle Scholar
• Nieuwenhuis E E, Matsumoto T, Exley M, Schleipman R A, Glickman J, Bailey D T, Corazza N, Colgan S P, Onderdonk A B, Blumberg R S. CD1d‐dependent macrophage‐mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8(6)588–593
   PubMedGoogle Scholar
• Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, Nakayama T, Taniguchi M, Saito A. Monocyte chemoattractant protein‐1‐dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 2001; 167(11)6525–6532
   PubMedGoogle Scholar
• Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18 + , BV11 + double‐negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001; 44(5)1127–1138
   PubMed Web of Science ®Google Scholar
• Lucas M, Gadola S, Meier U, Young N T, Harcourt G, Karadimitris A, Coumi N, Brown D, Dusheiko G, Cerundolo V, Klenerman P. Frequency and phenotype of circulating Vα24/Vβ11 double‐positive natural killer T cells during hepatitis C virus infection. J Virol 2003; 77(3)2251–2257
   PubMedGoogle Scholar